In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare In Brief

This article was originally published in The Gray Sheet

Executive Summary

MedCAC priority list: The Medicare Evidence Development and Coverage Advisory Committee will convene Oct. 22 to develop a list of priority research topics with the most potential impact on the Medicare program and its beneficiaries. The list will be a framework for the scientific community to advance evidence development, CMS says...

You may also be interested in...



Industry Digs Into Specifics Of CMS Proposal For Covering Clinical Trial Costs

Device industry representatives say CMS' latest proposed revision of its policy for covering certain clinical trial costs is a significant improvement over the previous proposal, but claim some specific requirements would be too burdensome on manufacturers

Ambulatory Surgical Center Payment Reform Enacted; Facilities Bitter

CMS finalized July 16 a restructured payment system for ambulatory surgical centers that the facilities claim will reduce payments for many procedures. The policy is an attempt by CMS to prevent reimbursement considerations from outweighing clinical considerations in determining where medical procedures are performed

New-Tech Inpatient Bonus Payments May Take Hiatus In FY 2008

Fiscal 2008 could be the first year that CMS makes no "new technology" bonus hospital inpatient payments since it began accepting industry applications for such payments in 2002

Related Content

UsernamePublicRestriction

Register

MT025209

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel